Glatiramer Acetate (Mylan Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the Glatiramer Acetate drug offered from Mylan Pharmaceuticals Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Mylan Pharmaceuticals Inc. |
| NON-PROPRIETARY NAME: | glatiramer acetate |
| SUBSTANCE NAME: | GLATIRAMER ACETATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | |
| ROUTE: | SUBCUTANEOUS |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2017-10-04 |
| END MARKETING DATE: | 0000-00-00 |
Glatiramer Acetate HUMAN PRESCRIPTION DRUG Details:
| Item Description | Glatiramer Acetate from Mylan Pharmaceuticals Inc. |
| LABELER NAME: | Mylan Pharmaceuticals Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 20(mg/mL) |
| START MARKETING DATE: | 2017-10-04 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0378-6960_f38b5606-d2d7-44ec-912f-46882aa2fa7b |
| PRODUCT NDC: | 0378-6960 |
| APPLICATION NUMBER: | ANDA091646 |
Other GLATIRAMER ACETATE Pharmaceutical Manufacturers / Labelers:
